Peanut Allergy Immunotherapy

Slides:

Advertisements

Similar presentations

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Advertisements

Systemic Lupus Erythematosus

New Psoriasis Treatments

Evolution of Treatment Strategies Targeting IL-23 for Psoriasis

Highlights From the 2017 Annual European MS Meeting

Improving Survival in Glioblastoma Multiforme

Advances in Managing Inhibitors in Patients With Hemophilia A

Allergy Testing in Children

Progression After Cancer Immunotherapy in Advanced NSCLC

The HCV Revolution: Are You and Your Practice Ready?

Induction Chemotherapy for Patients With High-Risk or Secondary AML

The Resurgence of Topical Treatments Across a Spectrum of Psoriasis

Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.

New Data in nAMD: What Does the Future Hold?

Addressing Disease Burden in Asthma

The Evolving Role of Immunotherapy in NSCLC

Immunotherapy in Pancreatic Cancer: Thinking Outside the Box

Optimizing Management of Advanced Bladder Cancer

Management Challenges in CLL

Addressing Challenges in Factor VIII Inhibitors in Children With Hemophilia.

Postpartum Depression

Implementing Best Practices in the Management of Allergic Diseases

The Emerging Role of Immunotherapy in Hodgkin Lymphoma

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Next-Gen Psoriasis Therapies:

Program Agenda. Advances in Peanut Allergy Immunotherapy: When Science Meets Technology.

Management of CMV in HSCT Recipients

Advances in Peanut Allergen Immunotherapy

Essential Concepts in the Use of Immunotherapies in Bladder Cancer

Ask the Experts.

Optimizing Outcomes and Managing Adverse Events in CLL

Immunotherapy for cSCC

Novel Approaches in T1D Management

Personalizing Management in the Care of Patients With Advanced Sarcoma

Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.

Developments in the Wet AMD Treatment Landscape

Advances in Peanut Allergy

Parkinson Disease Psychosis

Talking With Your Patients About Excessive Sweating

Advances in Immunotherapy for Peanut Allergy

Immune Checkpoint Inhibitors in Lung Cancer

Advances in Severe Asthma Management

Guide to Atopic Dermatitis

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

The Rising Cost of Healthcare and Potential Impact of Biosimilars

Peanut Allergy.

Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

Patient Questions and Expert Answers in Psoriasis:

Biomarker Testing: Harnessing All Sides of the Tumor Microenvironment

This program will include a discussion of off-label treatment and investigational agents not approved by the Food and Drug Administration for use in the.

Novel Concepts in the Management of RCC

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.

Peanut Allergy Immunotherapy

From Adjuvant to Metastatic in Melanoma

Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC

The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Case Studies in Locally Advanced Pancreatic Cancer

Peanut Allergy Immunotherapy

Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition

Checkpoint Inhibitors in First-Line Advanced NSCLC

VKA Reversal and LVADs.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Pathophysiologic Targets of Allergic Asthma

Case Studies in Peanut Allergy Immunotherapy

Finding the Right Sequence in Patients With EGFR-Mutated NSCLC

Using Biomarkers in MS: Initiating With the Right Therapy in Clinical Practice.

Immune Checkpoint Inhibitors in Lung Cancer

Comparative Studies of Biologics in Ulcerative Colitis

Presentation transcript:

Peanut Allergy Immunotherapy

This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

Peanut Allergy

Emerging Peanut Allergy Immunotherapies

Peanut Allergy Immunotherapy Purpose

Peanut Allergy Immunotherapy Benefit

Peanut Allergy Immunotherapy Unmet Need

Goals and Expectations of Immunotherapy Caregivers of Peanut Allergic Children

Modeling Risk Reduction of Reactivity to Peanut

Educating Patients

Food Challenges

Food Challenges RAMSES and PALISADE

Food Challenges Real-World Considerations

Potential Biomarkers

Potential Biomarkers Precision Medicine in the Future?

Therapy Selection Considerations

Therapy Selection Considerations Age

LEAP Study

Preparing Your Practice for Immunotherapy

Concluding Remarks

Abbreviations